Abbott Laboratories
ABT
$101.26
Share price
2.20%
Change (1 day)
-14.61%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Number of shares outstanding for Abbott Laboratories (ABT)
Number of shares outstanding as of April 2023 : 1,737,795,021
According to Abbott Laboratories's latest financial reports and stock price the company's current number of shares outstanding is 1,737,795,021. At the end of 2022 the company had 1,737,795,021 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Abbott Laboratories from 2001 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 1.73 B | -1.49% |
| 2021 | 1.76 B | -0.4% |
| 2020 | 1.77 B | 0.5% |
| 2019 | 1.76 B | 0.39% |
| 2018 | 1.75 B | 0.69% |
| 2017 | 1.74 B | 18.38% |
| 2016 | 1.47 B | 0.01% |
| 2015 | 1.47 B | -2.35% |
| 2014 | 1.50 B | -2.59% |
| 2013 | 1.54 B | 104.13% |
| 2012 | 0.75 B | 1.47% |
| 2011 | 0.74 B | 0.77% |
| 2010 | 0.74 B | -0.4% |
| 2009 | 0.74 B | 0.41% |
| 2008 | 0.74 B | 0.14% |
| 2007 | 0.74 B | 0.93% |
| 2006 | 0.73 B | -1.48% |
| 2005 | 0.74 B | -0.49% |
| 2004 | 0.74 B | 6.68% |
| 2003 | 0.70 B | 0.04% |
| 2002 | 0.70 B | 0.69% |
| 2001 | 0.69 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,627,900,000 | 51.22% | 🇺🇸 USA |
 Novartis NVS | 2,167,000,000 | 24.70% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,607,000,000 | 222.65% | 🇺🇸 USA |
 Medtronic MDT | 1,330,200,000 | -23.45% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 392,000,000 | -77.44% | 🇺🇸 USA |
 Boston Scientific BSX | 1,431,600,000 | -17.62% | 🇺🇸 USA |
 Hologic HOLX | 247,319,000 | -85.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,133,000,000 | 22.74% | 🇺🇸 USA |
 AstraZeneca AZN | 3,096,000,000 | 78.16% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,017,000,000 | 16.07% | 🇬🇧 UK |